Shalit, A.; Sarantis, P.; Koustas, E.; Trifylli, E.-M.; Matthaios, D.; Karamouzis, M.V.
Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment. Cancers 2023, 15, 375.
https://doi.org/10.3390/cancers15020375
AMA Style
Shalit A, Sarantis P, Koustas E, Trifylli E-M, Matthaios D, Karamouzis MV.
Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment. Cancers. 2023; 15(2):375.
https://doi.org/10.3390/cancers15020375
Chicago/Turabian Style
Shalit, Almog, Panagiotis Sarantis, Evangelos Koustas, Eleni-Myrto Trifylli, Dimitris Matthaios, and Michalis V. Karamouzis.
2023. "Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment" Cancers 15, no. 2: 375.
https://doi.org/10.3390/cancers15020375
APA Style
Shalit, A., Sarantis, P., Koustas, E., Trifylli, E.-M., Matthaios, D., & Karamouzis, M. V.
(2023). Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment. Cancers, 15(2), 375.
https://doi.org/10.3390/cancers15020375